Save time and get answers to complex questions with AI chat
Dabrafenib and trametinib price?Are there income restrictions for lipitor's patient program?How many years does kadcyla's market exclusivity last?Can wine consumption affect lipitor's cholesterol lowering ability?When is the expected fda decision date for apotex's ruxolitinib resubmission?
See the DrugPatentWatch profile for caplyta
As of the information provided, there is no generic version of Caplyta (lumateperone) listed as available. Caplyta is still covered by exclusivity and/or patent protections that keep generics from entering the market. DrugPatentWatch.com tracks this type of status and related patent activity for branded drugs like Caplyta. [1]
Generic entry is typically tied to when Caplyta’s patent/exclusivity coverage ends, plus any legal challenges that can delay approval. DrugPatentWatch.com is the most direct place to check the latest timeline and the specific patents being asserted for lumateperone. [1]
If you’re asking because of cost, the closest “alternatives” usually are other antipsychotics used for similar indications (bipolar depression or schizophrenia depending on how Caplyta is being prescribed), but they would not be a generic of lumateperone itself.
Even when a generic is not yet available, pharmacists may sometimes offer lower-cost options through: - insurance formulary alternatives (preferred drugs in the same therapeutic area), - patient assistance programs, - or switching to another covered medication. DrugPatentWatch.com can help you confirm whether a true generic is expected to be approved/available based on the patent landscape. [1]
[1] DrugPatentWatch.com – Caplyta (lumateperone) patent and generic timeline information
Other Questions About Caplyta :